ESRD (END-STAGE RENAL DISEASE)
Clinical trials for ESRD (END-STAGE RENAL DISEASE) explained in plain language.
Never miss a new study
Get alerted when new ESRD (END-STAGE RENAL DISEASE) trials appear
Sign up with your email to follow new studies for ESRD (END-STAGE RENAL DISEASE), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for dialysis patients: drug AP301 targets dangerous phosphorus levels
Disease control CompletedThis study tested a new drug called AP301 in 474 adults with kidney failure who are on dialysis and have high phosphorus levels. High phosphorus can cause bone and heart problems. The goal was to see if AP301 lowers phosphorus better than the current standard treatment, sevelamer…
Matched conditions: ESRD (END-STAGE RENAL DISEASE)
Phase: PHASE3 • Sponsor: Alebund Pharmaceuticals • Aim: Disease control
Last updated May 22, 2026 14:02 UTC
-
New dialysis gadget put to the test in small study
Knowledge-focused CompletedThis study tested a device called HemoCept to see if it can accurately measure fluid levels in people with kidney failure during dialysis. Twelve adults on dialysis for over 90 days took part. The goal was to see if the device's readings matched changes in the patient's dry weigh…
Matched conditions: ESRD (END-STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated May 26, 2026 06:00 UTC
-
AI could predict dialysis complications before they happen
Knowledge-focused CompletedThis study looked at data from 778 adults on long-term hemodialysis to build an AI system that can warn doctors early if a patient's dialysis is not working well enough. The goal is to predict serious problems like heart disease or stroke before they occur. The research is observ…
Matched conditions: ESRD (END-STAGE RENAL DISEASE)
Sponsor: Huashan Hospital • Aim: Knowledge-focused
Last updated May 26, 2026 05:58 UTC
-
Can a simple device improve dialysis fluid tracking?
Knowledge-focused CompletedThis study tested a device called HemoCept to see if it can accurately measure how much fluid is removed during dialysis. 26 adults with end-stage kidney disease participated. The goal was to compare the device's readings with actual changes in the patients' dry weight.
Matched conditions: ESRD (END-STAGE RENAL DISEASE)
Sponsor: HemoCept Inc. • Aim: Knowledge-focused
Last updated May 22, 2026 13:54 UTC